{3 Little Diabetes Things} 12.26.2016

by Leighann on December 26, 2016

3 Little Things 12-26-2016

I sometimes have a “little” something to say about diabetes…

Alan ThickeAlan Thicke Dies

Did you know that Alan Thicke was a d-dad and raised awareness about type 1 diabetes?

Read “Alan Thicke, ’80s Sitcom Dad And Theme Song Composer, Dies At 69” on NPR.

From the JDRF Press Release

His son, Brennan, was diagnosed with T1D at age 4 after a revelation at a family reunion. Alan’s stepmother, a nurse, noticed that Brennan was exhibiting the symptoms of type 1 diabetes – including extreme thirst and excessive trips to the bathroom. In a recent interview, Thicke described how the first months after Brennan’s diagnosis were especially stressful and scary: “After hours of cajoling and chasing him around the house I had to pin him to the floor to give him his [insulin] shot. He was kicking and screaming.” When Thicke was reduced to tears, young Brennan came to a realization. “He recognized he wasn’t being punished by getting a shot, and that the shots were hurting me almost as much as they were hurting him… That changed our whole relationship. He realized we were a team.”

Fight T1D Kids

This made me laugh so hard. Q thought it was pretty funny too. My money is on kids with diabetes…they are pretty tough!

(Source unknown.)

FDA Approves Dexcom G5 For Insulin Dosing

We are still using the Dexcom G4, so I can’t speak to the accuracy of the readings given by the G5 system. But only having to do morning and evening calibrations and relying on the Dex for blood glucose readings for insulin dosing decisions sounds great.

I do have a concern that insurance companies will stop covering as many test strips for patients who also use Dexcom.

What do you think about trusting Dex for dosing decisions?

The U.S. Food and Drug Administration today expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes. This is the first FDA-approved continuous glucose monitoring system that can be used to make diabetes treatment decisions without confirmation with a traditional fingerstick test. The system was previously approved to complement, not replace, fingerstick testing for diabetes treatment decisions.

Read the entire press release “FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions.”

You Might Also Like…

More 3 Little Diabetes Things posts

More posts about continuous glucose monitors (CGM)

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: